Literature DB >> 33499072

Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function.

Laura Monza1,2, Giulia Fumagalli1,2, Alessia Chiorazzi1,2, Paola Alberti1,2.   

Abstract

Peripheral neuropathies (PNs) are a type of common disease that hampers the quality of life of affected people. Treatment, in most cases, is just symptomatic and often ineffective. To improve drug discovery in this field, preclinical evidence is warranted. In vivo rodent models allow a multiparametric approach to test new therapeutic strategies, since they can allow pathogenetic and morphological studies different from the clinical setting. However, human readouts are warranted to promptly translate data from the bench to the bedside. A feasible solution would be neurophysiology, performed similarly at both sides. We describe a simple protocol that reproduces the standard clinical protocol of a neurophysiology hospital department. We devised the optimal montage for sensory and motor recordings (neurography) in mice, and we also implemented F wave testing and a short electromyography (EMG) protocol at rest. We challenged this algorithm by comparing control animals (BALB/c mice) with a model of mild neuropathy to grasp even subtle changes. The neurophysiological results were confirmed with neuropathology. The treatment group showed all expected alterations. Moreover, the neurophysiology matched the neuropathological analyses. Therefore, our protocol can be suggested to promptly translate data from the bench to the bedside and vice versa.

Entities:  

Keywords:  EMG; animal models; nerve conduction studies; neuropathology; neuropathy; neurophysiology; translational medicine

Year:  2021        PMID: 33499072      PMCID: PMC7911498          DOI: 10.3390/brainsci11020139

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  53 in total

Review 1.  The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients.

Authors:  James W Mold; Sara K Vesely; Barbara A Keyl; Joan B Schenk; Michelle Roberts
Journal:  J Am Board Fam Pract       Date:  2004 Sep-Oct

2.  Niclosamide Inhibits Oxaliplatin Neurotoxicity while Improving Colorectal Cancer Therapeutic Response.

Authors:  Olivier Cerles; Evelyne Benoit; Christiane Chéreau; Sandrine Chouzenoux; Florence Morin; Marie-Anne Guillaumot; Romain Coriat; Niloufar Kavian; Thomas Loussier; Pietro Santulli; Louis Marcellin; Nathaniel E B Saidu; Bernard Weill; Frédéric Batteux; Carole Nicco
Journal:  Mol Cancer Ther       Date:  2016-12-15       Impact factor: 6.261

3.  An exercise regimen prevents development paclitaxel induced peripheral neuropathy in a mouse model.

Authors:  Jae Sung Park; Sangri Kim; Ahmet Hoke
Journal:  J Peripher Nerv Syst       Date:  2015-03       Impact factor: 3.494

Review 4.  AAEM minimonograph #44: diseases associated with excess motor unit activity.

Authors:  R G Auger
Journal:  Muscle Nerve       Date:  1994-11       Impact factor: 3.217

5.  Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.

Authors:  Andreas A Argyriou; Guido Cavaletti; Anna Antonacopoulou; Armando A Genazzani; Chiara Briani; Jordi Bruna; Salvatore Terrazzino; Roser Velasco; Paola Alberti; Marta Campagnolo; Sara Lonardi; Diego Cortinovis; Marina Cazzaniga; Cristina Santos; Aikaterini Psaromyalou; Aikaterini Angelopoulou; Haralabos P Kalofonos
Journal:  Cancer       Date:  2013-07-02       Impact factor: 6.860

6.  Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.

Authors:  Paola Alberti; Annalisa Canta; Alessia Chiorazzi; Giulia Fumagalli; Cristina Meregalli; Laura Monza; Eleonora Pozzi; Elisa Ballarini; Virginia Rodriguez-Menendez; Norberto Oggioni; Giulio Sancini; Paola Marmiroli; Guido Cavaletti
Journal:  Neuropharmacology       Date:  2019-12-04       Impact factor: 5.250

Review 7.  Peripheral Neuropathy.

Authors:  Kelsey Barrell; A Gordon Smith
Journal:  Med Clin North Am       Date:  2018-12-17       Impact factor: 5.456

8.  Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients.

Authors:  A A Argyriou; R Velasco; C Briani; G Cavaletti; J Bruna; P Alberti; M Cacciavillani; S Lonardi; C Santos; D Cortinovis; M Cazzaniga; H P Kalofonos
Journal:  Ann Oncol       Date:  2012-08-02       Impact factor: 32.976

9.  Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.

Authors:  Susanna B Park; David Goldstein; Cindy S-Y Lin; Arun V Krishnan; Michael L Friedlander; Matthew C Kiernan
Journal:  J Clin Oncol       Date:  2009-01-21       Impact factor: 44.544

10.  Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice.

Authors:  Cynthia L Renn; Valentina A Carozzi; Peter Rhee; Danisha Gallop; Susan G Dorsey; Guido Cavaletti
Journal:  Mol Pain       Date:  2011-04-26       Impact factor: 3.395

View more
  2 in total

1.  Nerve Biopsy in Peripheral Neuropathies: Not All Water Is under the Bridge.

Authors:  Marco Luigetti; Andrea Di Paolantonio
Journal:  Brain Sci       Date:  2021-04-27

2.  Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?

Authors:  Elisa Ballarini; Alessio Malacrida; Virginia Rodriguez-Menendez; Eleonora Pozzi; Annalisa Canta; Alessia Chiorazzi; Laura Monza; Sara Semperboni; Cristina Meregalli; Valentina Alda Carozzi; Maryamsadat Hashemi; Gabriella Nicolini; Arianna Scuteri; Stephen N Housley; Guido Cavaletti; Paola Alberti
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.